A Tribute to George A. Jacoby

Same author

Enhancing clinical utility of AI-based antimicrobial resistance models: a perspective.

mBio·2026

Same author

Standardized numbering and alignment of the KPC family of β-lactamases.

Antimicrobial agents and chemotherapy·2026

Same author

Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant Pseudomonas aeruginosa and clinical implications in the prospective observational Pseudomonas study.

Antimicrobial agents and chemotherapy·2026

Same author

Sulbactam-durlobactam and cefiderocol combination treatment of Burkholderia cenocepacia-associated Fitz-Hugh-Curtis syndrome.

Antimicrobial agents and chemotherapy·2026

Same author

Role of Ambler Position 104 in Defining Substrate Specificity in the KPC Family of β-Lactamases.

ACS infectious diseases·2026

Same author

A Val292 substitution combined with an alanine duplication (ADUP) in the Ω loop of ADC β-lactamase confers reduced susceptibility to advanced β-lactam agents, including cefiderocol.

mBio·2026

Same journal

Isavuconazole for invasive mold disease in patients with hematological malignancies: a multicenter real-world study from China on efficacy, safety, and competing risks.

Antimicrobial agents and chemotherapy·2026

Same journal

An Achilles' heel for methicillin-resistant Staphylococcus aureus? Re-evaluating β-lactam susceptibility of MRSA.

Antimicrobial agents and chemotherapy·2026

Same journal

Essential role of glycogen synthase kinase 3 in regulating growth, drug response, and infectivity in Leishmania infantum.

Antimicrobial agents and chemotherapy·2026

Same journal

In vitro antibacterial activity of gepotidacin in combination with other antimicrobial agents against Neisseria gonorrhoeae isolates.

Antimicrobial agents and chemotherapy·2026

Same journal

Development of domain-specific probes of Plasmodium falciparum heat shock protein 70-1.

Antimicrobial agents and chemotherapy·2026

Same journal

Addressing therapeutic options for KPC-3-producing ST307-Klebsiella pneumoniae: insights from in vitro evolution and mutant prevention strategies.

Antimicrobial agents and chemotherapy·2026

Related Experiment Videos

A Tribute to George A. Jacoby

Related Concept Videos

Enhancing clinical utility of AI-based antimicrobial resistance models: a perspective.

Standardized numbering and alignment of the KPC family of β-lactamases.

Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and clinical implications in the prospective observational <i>Pseudomonas</i> study.

Sulbactam-durlobactam and cefiderocol combination treatment of <i>Burkholderia cenocepacia</i>-associated Fitz-Hugh-Curtis syndrome.

Role of Ambler Position 104 in Defining Substrate Specificity in the KPC Family of β-Lactamases.

A Val292 substitution combined with an alanine duplication (ADUP) in the Ω loop of ADC β-lactamase confers reduced susceptibility to advanced β-lactam agents, including cefiderocol.

Isavuconazole for invasive mold disease in patients with hematological malignancies: a multicenter real-world study from China on efficacy, safety, and competing risks.

An Achilles' heel for methicillin-resistant <i>Staphylococcus aureus</i>? Re-evaluating β-lactam susceptibility of MRSA.

Essential role of glycogen synthase kinase 3 in regulating growth, drug response, and infectivity in <i>Leishmania infantum</i>.

<i>In vitro</i> antibacterial activity of gepotidacin in combination with other antimicrobial agents against <i>Neisseria gonorrhoeae</i> isolates.

Development of domain-specific probes of <i>Plasmodium falciparum</i> heat shock protein 70-1.

Addressing therapeutic options for KPC-3-producing ST307-<i>Klebsiella pneumoniae</i>: insights from <i>in vitro</i> evolution and mutant prevention strategies.

Related Experiment Videos

A Tribute to George A. Jacoby

Related Concept Videos

Related Articles

Enhancing clinical utility of AI-based antimicrobial resistance models: a perspective.

Standardized numbering and alignment of the KPC family of β-lactamases.

Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and clinical implications in the prospective observational <i>Pseudomonas</i> study.

Sulbactam-durlobactam and cefiderocol combination treatment of <i>Burkholderia cenocepacia</i>-associated Fitz-Hugh-Curtis syndrome.

Role of Ambler Position 104 in Defining Substrate Specificity in the KPC Family of β-Lactamases.

A Val292 substitution combined with an alanine duplication (ADUP) in the Ω loop of ADC β-lactamase confers reduced susceptibility to advanced β-lactam agents, including cefiderocol.

Isavuconazole for invasive mold disease in patients with hematological malignancies: a multicenter real-world study from China on efficacy, safety, and competing risks.

An Achilles' heel for methicillin-resistant <i>Staphylococcus aureus</i>? Re-evaluating β-lactam susceptibility of MRSA.

Essential role of glycogen synthase kinase 3 in regulating growth, drug response, and infectivity in <i>Leishmania infantum</i>.

<i>In vitro</i> antibacterial activity of gepotidacin in combination with other antimicrobial agents against <i>Neisseria gonorrhoeae</i> isolates.

Development of domain-specific probes of <i>Plasmodium falciparum</i> heat shock protein 70-1.

Addressing therapeutic options for KPC-3-producing ST307-<i>Klebsiella pneumoniae</i>: insights from <i>in vitro</i> evolution and mutant prevention strategies.